Moreover, ROC curves indicated that TP73 expression could predict the OS of 1‐year, 2‐year and 3‐years with considerable predictability in different cohorts of WHO grade II/III glioma (Figure 2C, Figure S2B–C). Here, TP73 is linked to central nervous system cancer.